Christopher C. Pennil

3.4k total citations · 2 hit papers
21 papers, 2.4k citations indexed

About

Christopher C. Pennil is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Christopher C. Pennil has authored 21 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Christopher C. Pennil's work include BRCA gene mutations in cancer (14 papers), Ovarian cancer diagnosis and treatment (9 papers) and PARP inhibition in cancer therapy (9 papers). Christopher C. Pennil is often cited by papers focused on BRCA gene mutations in cancer (14 papers), Ovarian cancer diagnosis and treatment (9 papers) and PARP inhibition in cancer therapy (9 papers). Christopher C. Pennil collaborates with scholars based in United States, Germany and Slovakia. Christopher C. Pennil's co-authors include Elizabeth M. Swisher, Rochelle L. Garcia, Barbara M. Norquist, Tom Walsh, Mary‐Claire King, Anne Thornton, Silvia Casadei, Ming K. Lee, Alex S. Nord and Kathy Agnew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Christopher C. Pennil

19 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

2013 712 citations Kathryn P. Pennington, Tom Walsh et al. Clinical Cancer Research profile →
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

2011 662 citations Tom Walsh, Silvia Casadei et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher C. Pennil United States	11	1.2k	1.2k	1.2k	876	586	21	2.4k
Jolanta Kupryjańczyk Poland	23	485 0.4×	839 0.7×	278 0.2×	606 0.7×	472 0.8×	70	1.7k
Óskar Þór Jóhannsson Sweden	17	615 0.5×	673 0.6×	1.0k 0.9×	215 0.2×	634 1.1×	27	1.7k
Michael Churchman United Kingdom	21	409 0.3×	473 0.4×	125 0.1×	371 0.4×	223 0.4×	45	1.1k
J. F. Lynch United States	22	1.6k 1.3×	509 0.4×	526 0.5×	78 0.1×	772 1.3×	52	2.4k
Kirstin M. Roundy United States	11	708 0.6×	322 0.3×	250 0.2×	80 0.1×	490 0.8×	16	1.4k
Ann Kalita Canada	10	1.3k 1.0×	1.4k 1.2×	136 0.1×	41 0.0×	337 0.6×	11	2.2k
Kerstin Heselmeyer Sweden	12	414 0.3×	545 0.5×	433 0.4×	53 0.1×	490 0.8×	16	1.3k
Maria J. Worsham United States	29	592 0.5×	1.0k 0.9×	401 0.3×	24 0.0×	516 0.9×	82	2.1k
Sander R. van Hooff Netherlands	16	362 0.3×	528 0.4×	72 0.1×	105 0.1×	223 0.4×	29	1.0k
Jennifer D. Thompson United States	8	392 0.3×	405 0.3×	543 0.5×	71 0.1×	308 0.5×	11	1.2k

Countries citing papers authored by Christopher C. Pennil

Since Specialization

Citations

This map shows the geographic impact of Christopher C. Pennil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Pennil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Pennil more than expected).

Fields of papers citing papers by Christopher C. Pennil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Pennil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Pennil. The network helps show where Christopher C. Pennil may publish in the future.

Co-authorship network of co-authors of Christopher C. Pennil

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Pennil. A scholar is included among the top collaborators of Christopher C. Pennil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Pennil. Christopher C. Pennil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krumm, Niklas, Marc R. Radke, Kalyan Banda, et al.. (2023). Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays. JCO Precision Oncology. 7(7). e2200720–e2200720. 3 indexed citations

Rodríguez, Isabel, Shu Liang, Christopher C. Pennil, et al.. (2023). Constitutional BRCA1 and RAD51C methylation associated with corresponding gene methylation in BRCA wildtype ovarian cancer (156). Gynecologic Oncology. 176. S55–S56. 1 indexed citations

Swisher, Elizabeth M., Austin Miller, Elise C. Kohn, et al.. (2021). LBA34 Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004. Annals of Oncology. 32. S1309–S1309. 4 indexed citations

Somasegar, Sahana, Barbara M. Norquist, Marc R. Radke, et al.. (2021). Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas. Gynecologic Oncology. 163(1). 130–133. 6 indexed citations

Somasegar, Sahana, Barbara M. Norquist, Marc R. Radke, et al.. (2021). Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas. Gynecologic Oncology. 164(1). 32–32. 1 indexed citations

Rodríguez, Isabel, Christina Smith, Christopher C. Pennil, et al.. (2021). Development and validation of a novel quantitative BRCA1 promoter methylation assay in ovarian carcinoma. Gynecologic Oncology. 164(1). 4–4. 1 indexed citations

Hořčičková, Michaela, Mark E. Clark, Martin Kváč, et al.. (2017). Cryptosporidiuminfecting wild cricetid rodents from the subfamilies Arvicolinae and Neotominae. Parasitology. 145(3). 326–334. 19 indexed citations

Pennington, Kathryn P., Tom Walsh, Maria I. Harrell, et al.. (2013). Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas. Clinical Cancer Research. 20(3). 764–775. 712 indexed citations breakdown →

Pennington, Kathryn P., Tom Walsh, Maria I. Harrell, et al.. (2013). Germline and somatic mutations in homologous recombination genes predict platinum response and improved overall survival in ovarian, fallopian tube, and peritoneal carcinomas. Gynecologic Oncology. 131(1). 257–258. 2 indexed citations

10.

Pennington, Kathryn P., Tom Walsh, Maria I. Harrell, et al.. (2013). Deep sequencing reveals a high rate of temporal heterogeneity of somatic mutations in paired primary and recurrent ovarian carcinomas. Gynecologic Oncology. 131(1). 258–258.

11.

Press, Joshua Z., Morayma Reyes, Sharon J. Pitteri, et al.. (2012). Microparticles From Ovarian Carcinomas Are Shed Into Ascites and Promote Cell Migration. International Journal of Gynecological Cancer. 22(4). 546–552. 31 indexed citations

12.

Norquist, Barbara M., Kathryn P. Pennington, Kathy Agnew, et al.. (2012). Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing. Gynecologic Oncology. 128(3). 483–487. 21 indexed citations

13.

Pennil, Christopher C., Silvia Casadei, Kathy Agnew, et al.. (2012). Loss of function germline mutations in RAD51D in women with ovarian carcinoma. Gynecologic Oncology. 127(3). 552–555. 28 indexed citations

14.

Pennington, Kathryn P., Tom Walsh, Ming Lee, et al.. (2012). BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer. 119(2). 332–338. 78 indexed citations

15.

Pennington, Kathryn P., Anneka Wickramanayake, Barbara M. Norquist, et al.. (2012). 53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes. Gynecologic Oncology. 128(3). 493–499. 24 indexed citations

16.

Wickramanayake, Anneka, Christopher C. Pennil, Tom Walsh, et al.. (2012). Loss of function germline mutations in RAD51D are present in 1% of unselected women with ovarian carcinoma. Gynecologic Oncology. 125. S6–S6. 1 indexed citations

17.

Walsh, Tom, Silvia Casadei, Ming K. Lee, et al.. (2011). Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences. 108(44). 18032–18037. 662 indexed citations breakdown →

18.

Norquist, Barbara M., Kaitlyn Wurz, Christopher C. Pennil, et al.. (2011). Secondary Somatic Mutations RestoringBRCA1/2Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas. Journal of Clinical Oncology. 29(22). 3008–3015. 436 indexed citations

19.

Press, Joshua Z., Kaitlyn Wurz, Barbara M. Norquist, et al.. (2010). Identification of a Preneoplastic Gene Expression Profile in Tubal Epithelium of BRCA1 Mutation Carriers. Neoplasia. 12(12). 993–IN8. 19 indexed citations

20.

Walsh, Tom, Ming K. Lee, Silvia Casadei, et al.. (2010). Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proceedings of the National Academy of Sciences. 107(28). 12629–12633. 325 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact